bioavailability study
Showing 1 - 4 of 4
Bioavailability Study Trial in Ghent (MP29-02, Fluticasone propionate)
Withdrawn
- Bioavailability Study
- MP29-02
- Fluticasone propionate
-
Ghent, BelgiumUniversity Hospital Ghent, departement otorhinolaryngology
Jul 7, 2021
Bioavailability Study Trial in Hefei (Hetrombopag)
Completed
- Bioavailability Study
-
Hefei, Anhui, ChinaThe Second Hospital of Anhui Medical University
Feb 24, 2021
Bioavailability Study Trial in Miami (NPC-12G Gel 0.2%, Rapamune® 2 mg tablet)
Completed
- Bioavailability Study
- NPC-12G Gel 0.2%
- Rapamune® 2 mg tablet
-
Miami, FloridaInVentiv Health Clinical Research Services LLC
Mar 4, 2020